rituximab,ibrutinib,Bendamustine
biogen,roche,novartis,janssen,abbvie
['shine', 'lymphoma']
 presenting the phase iii shine trial showing benefit of ibrutinib + br vs. br in elderly transplant ineligible pts with #mcl #lymphoma #asco22 
Assist-Prof of Med, @MayoClinic FL, #ASCOTEC, ASCO AMEC. #Lymphoma #PTCL #CTCL #histiocyticDiseases #ClinicalResearch ?????? ????? ?? ?????? #???????